Professor Matthew Brown, Director of the University of Queensland Diamantina Institute

Professor Matthew Brown

MBBS, MD, FRACP

Phone: + 61 (7) 3176 5954
Fax: + 61 (7) 3176 5946
Email: di.director@uq.edu.au
Website: www.di.uq.edu.au
Office: UQ Diamantina Institute
Post: 4th Floor R-Wing,
Building 1, Princess Alexandra Hospital
Ipswich Road
Woolloongabba
QLD 4102

Executive Assistant:
Sarah Macaione
Tel: +61 (7) 3176 5954
Email: s.macaione@uq.edu.au

Areas of Responsibility:
Matthew Brown is the Director of The University of Queensland Diamantina Institute, based at the Princess Alexandra Hospital in Brisbane. This institute is made up of over 200 researchers, clinical researchers, students and support staff. Professor Browns’s current research interests include human bone and joint diseases, particularly focussing on ankylosing spondylitis and osteoporosis. Professor Brown is a Group Leader of the Autoimmunity division, and focuses on genetics of common diseases, particularly musculoskeletal.

Biography:
Professor Brown is currently Professor of Immunogenetics at, and Director of The University of Queensland’s Diamantina Institute (UQDI). He is also visiting professor at UQs Queensland Brain Institute and at University of Oxford.

Since returning to Australia from University of Oxford in 2005 where he held the chair in Musculoskeletal Sciences, he has built up a research unit at UQDI which is amongst the leading human genetics units internationally, particularly in human bone and joint diseases, particularly focussing on ankylosing spondylitis and osteoporosis. The group includes 30 researchers, and is well equipped with microarray genotyping and gene-expression technology, and next-generation sequencing capacity (four next-generation sequencers).

Being housed within a translational research institute, it is well placed to both identify genes, and then to translate those findings back to patient-relevant findings such as determining the mechanisms underlying the disease-associations.

As a clinician-scientist still clinically active in rheumatology practice, translation is a major goal of his research.

On this site